ZIP4 Is a Novel Cancer Stem Cell Marker in High-Grade Serous Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer is the most deadly gynecologic cancer. The treatment options for ovarian cancer, and for the recurrent cancer in particular, are limited. One of the major obstacles is the presence of drug-resistant cancer stem cells. The aim of this study is to identify and characteri...

Descripción completa

Detalles Bibliográficos
Autores principales: Fan, Qipeng, Zhang, Wen, Emerson, Robert E., Xu, Yan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764492/
https://www.ncbi.nlm.nih.gov/pubmed/33316986
http://dx.doi.org/10.3390/cancers12123692

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7764492/
https://www.ncbi.nlm.nih.gov/pubmed/33316986
http://dx.doi.org/10.3390/cancers12123692

Ejemplares similares